Carnegie Investment Counsel’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $231K | Sell |
|
|||||
|
2025
Q2 | $308K | Hold |
|
|||||
|
2025
Q1 | $218K | Hold |
|
|||||
|
2024
Q4 | $275K | Buy |
|
|||||
|
2024
Q3 | $213K | Sell |
|
|||||
|
2024
Q2 | $595K | Sell |
|
|||||
|
2024
Q1 | $742K | Sell |
|
|||||
|
2023
Q4 | $671K | Buy |
|
|||||
|
2023
Q3 | $505K | Buy |
|
|||||
|
2023
Q2 | $687K | Buy |
|
|||||
|
2023
Q1 | $617K | Sell |
|
|||||
|
2022
Q4 | $602K | Buy |
|
|||||
|
2022
Q3 | $428K | Hold |
|
|||||
|
2022
Q2 | $396K | Buy |
|
|||||
|
2022
Q1 | $626K | Sell |
|
|||||
|
2021
Q4 | $704K | Buy |
|
|||||
|
2021
Q3 | $640K | Buy |
|
|||||
|
2021
Q2 | $398K | Hold |
|
|||||
|
2021
Q1 | $335K | Buy |
|
|||||
|
2020
Q4 | $332K | Sell |
|
|||||
|
2020
Q3 | $391K | Buy |
|
|||||
|
2020
Q2 | $247K | Buy |
|